{"id":3405,"date":"2018-11-27T19:14:25","date_gmt":"2018-11-27T17:14:25","guid":{"rendered":"https:\/\/mereusanatosi.ro\/wp\/?p=3405"},"modified":"2019-01-11T15:38:57","modified_gmt":"2019-01-11T13:38:57","slug":"medicament-nou-pentru-tratarea-migrenei-aprobat-de-uniunea-europeana","status":"publish","type":"post","link":"https:\/\/mereusanatosi.ro\/wp\/2018\/11\/27\/medicament-nou-pentru-tratarea-migrenei-aprobat-de-uniunea-europeana\/","title":{"rendered":"Medicament nou pentru tratarea migrenei, aprobat de Uniunea European\u0103"},"content":{"rendered":"

\"\"<\/p>\n

Comitetul pentru medicamente de uz uman al Agen\u021biei Europene a Medicamentului <\/span>a recomandat acordarea autoriza\u0163iei de comercializare a <\/span><\/span>medicamentul Emgality, <\/span>utilizat \u00een<\/span><\/span> prevenirea migrenei. <\/span><\/span><\/span><\/p>\n

De\u0219i <\/span>nu se cunosc cu exactitate cauzele care declan\u015feaz\u0103 acest\u0103 afec\u0163iune<\/span>, se presupune c\u0103 migrena este o tulburare neurovascular\u0103, care<\/span> ac\u021bioneaz\u0103 la <\/span>nivel cerebral al vaselor de s\u00e2nge din zona<\/span> capului. Boala are <\/span>o component\u0103 genetic\u0103 puternic\u0103, femeile fiind mai afectate dec\u00e2t b\u0103rba\u0163ii. <\/span><\/span><\/span><\/p>\n

Emgality <\/span>este disponibil sub form\u0103 de<\/span><\/span> solu\u021bie injectabil\u0103 <\/span>\u015fi va fi prescris <\/span><\/span>doar pentru pacien\u021bii cu minimum 4 zile de migren\u0103 \/ <\/span>lun\u0103<\/span><\/span>. Beneficiile <\/span>medicamentului <\/span><\/span> au fost <\/span>analizate prin <\/span><\/span>trei studii pivot, la care au participat 1780 pacien\u021bi cu migren\u0103 episodic\u0103 \u0219i 1117 pacien\u021bi cu migren\u0103 cronic\u0103. Dup\u0103 \u0219ase luni de tratament, pacien\u021bii cu migren\u0103 episodic\u0103 <\/span>au \u00eenregistrat o <\/span><\/span>reducere de 1,9 \u00een medie a zilelor cu migren\u0103 pe lun\u0103, comparativ cu <\/span>gruul care a primit tratament <\/span><\/span>placebo. La pacien\u021bii cu migren\u0103 cronic\u0103, reducerea a fost de 2 zile. <\/span><\/span><\/span><\/p>\n

Reac\u0163iile adverse la acest medicament <\/span><\/span>sunt durere \u0219i <\/span>irita\u0163ie<\/span><\/span> la locul inject\u0103rii, <\/span>ame\u0163eli<\/span><\/span> \u0219i constipa\u021bi<\/span>e<\/span><\/span>.<\/span><\/span><\/span><\/p>\n

Tratamentul cu<\/span><\/span> Emgality constituie cea de-a doua terapie cu anticorpi monoclonali <\/span>recomandat<\/span><\/span>pentru prevenirea migrenei. <\/span>\u00cen luna mai 2018, Comitetul pentru medicamente de uz uman a aprobat comercializarea unui alt medicament anti-migren\u0103, Aimovig. <\/span><\/span><\/span><\/span><\/p>\n

Dup\u0103 acordarea autoriza\u0163iei, fiecare stat membru al UE va decide singur asupra pre\u021bului \u0219i a modului rambursare, dup\u0103 o analiz\u0103 a necesit\u0103\u0163ii medicamentului \u00een sistemul na\u021bional de s\u0103n\u0103tate al \u021b\u0103rii respective. <\/span><\/span><\/span><\/span><\/p>\n

 <\/p>\n

sursa: https:\/\/www.ema.europa.eu\/news\/new-medicine-prevention-migraine<\/a><\/span><\/span><\/span><\/span><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

Comitetul pentru medicamente de uz uman al Agen\u021biei Europene a Medicamentului a recomandat acordarea autoriza\u0163iei de comercializare a medicamentul Emgality,<\/p>\n","protected":false},"author":5,"featured_media":2117,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[177,167,359],"tags":[1174,1173],"_links":{"self":[{"href":"https:\/\/mereusanatosi.ro\/wp\/wp-json\/wp\/v2\/posts\/3405"}],"collection":[{"href":"https:\/\/mereusanatosi.ro\/wp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereusanatosi.ro\/wp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereusanatosi.ro\/wp\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/mereusanatosi.ro\/wp\/wp-json\/wp\/v2\/comments?post=3405"}],"version-history":[{"count":1,"href":"https:\/\/mereusanatosi.ro\/wp\/wp-json\/wp\/v2\/posts\/3405\/revisions"}],"predecessor-version":[{"id":3406,"href":"https:\/\/mereusanatosi.ro\/wp\/wp-json\/wp\/v2\/posts\/3405\/revisions\/3406"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/mereusanatosi.ro\/wp\/wp-json\/wp\/v2\/media\/2117"}],"wp:attachment":[{"href":"https:\/\/mereusanatosi.ro\/wp\/wp-json\/wp\/v2\/media?parent=3405"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereusanatosi.ro\/wp\/wp-json\/wp\/v2\/categories?post=3405"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereusanatosi.ro\/wp\/wp-json\/wp\/v2\/tags?post=3405"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}